Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
- PMID: 15072852
- DOI: 10.1016/j.molimm.2003.12.002
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?
Abstract
The complement system constitutes an important component of the defence against foreign organisms, functioning both in innate and adaptive immune systems. It is potentially harmful also to the own organism and is therefore tightly regulated by a number of membrane-bound and soluble factors. C4b-binding protein (C4BP) is a potent circulating soluble inhibitor of the classical and lectin pathways of complement. In recent years, the relationships between the structure of C4BP and its functions have been elucidated using a combination of computer-based molecular analysis and recombinant DNA technologies. Moreover, two novel functions have recently been ascribed to C4BP. One is the ability of C4BP to localize complement regulatory activity to the surface of apoptotic cells via its interaction with the membrane-binding vitamin K-dependent protein S. The other is the ability of C4BP to act as a survival factor for B cells due to an interaction with CD40. The complement regulatory activity of C4BP is not only beneficial because it is also explored by pathogens such as Neisseria gonorrhoeae, Bordetella pertussis, Streptococcus pyogenes, Escherichia coli K1, and Candida albicans, that bind C4BP to their surfaces. This contributes to the serum resistance and the pathogenicity of these bacteria. In this review, the structural requirements and functional importance of the interactions between C4BP and its various ligands are discussed.
Similar articles
-
Structural and functional studies of complement inhibitor C4b-binding protein.Biochem Soc Trans. 2002 Nov;30(Pt 6):978-82. doi: 10.1042/bst0300978. Biochem Soc Trans. 2002. PMID: 12440957 Review.
-
Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b.Eur J Immunol. 2001 Sep;31(9):2771-80. doi: 10.1002/1521-4141(200109)31:9<2771::aid-immu2771>3.0.co;2-0. Eur J Immunol. 2001. PMID: 11536176
-
The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein.Infect Immun. 2004 Nov;72(11):6633-41. doi: 10.1128/IAI.72.11.6633-6641.2004. Infect Immun. 2004. PMID: 15501796 Free PMC article.
-
The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):469-75. doi: 10.1042/bj3230469. Biochem J. 1997. PMID: 9163340 Free PMC article.
-
Studies on the interaction between vitamin K-dependent protein S and complement regulator C4b-binding protein: localization of binding sites and identification of a possible function of the complex.Scand J Clin Lab Invest Suppl. 2002;237:19-28. doi: 10.1080/003655102762377457. Scand J Clin Lab Invest Suppl. 2002. PMID: 12570163 Review.
Cited by
-
The Complement Component 4 Binding Protein α Gene: A Versatile Immune Gene That Influences Lipid Metabolism in Bovine Mammary Epithelial Cell Lines.Int J Mol Sci. 2024 Feb 17;25(4):2375. doi: 10.3390/ijms25042375. Int J Mol Sci. 2024. PMID: 38397050 Free PMC article.
-
Heavy chains of inter alpha inhibitor (IαI) inhibit the human complement system at early stages of the cascade.J Biol Chem. 2012 Jun 8;287(24):20100-10. doi: 10.1074/jbc.M111.324913. Epub 2012 Apr 23. J Biol Chem. 2012. PMID: 22528482 Free PMC article. Clinical Trial.
-
Complement activation: an emerging player in the pathogenesis of cardiovascular disease.Scientifica (Cairo). 2012;2012:402783. doi: 10.6064/2012/402783. Epub 2012 Dec 16. Scientifica (Cairo). 2012. PMID: 24278688 Free PMC article. Review.
-
Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3.PLoS Pathog. 2009 Feb;5(2):e1000316. doi: 10.1371/journal.ppat.1000316. Epub 2009 Feb 27. PLoS Pathog. 2009. PMID: 19247445 Free PMC article.
-
Identification of contributing genes of Huntington's disease by machine learning.BMC Med Genomics. 2020 Nov 23;13(1):176. doi: 10.1186/s12920-020-00822-w. BMC Med Genomics. 2020. PMID: 33228685 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous